VIROXIS S A S has a total of 13 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are ADMEDUS VACCINES PTY LTD, ID LELYSTAD INST DIERHOUDERIJ and BAVARIAN NORDIC AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | India | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Heidmann Thierry | 12 |
#2 | Thierry Heidmann | 1 |
Publication | Filing date | Title |
---|---|---|
EP3004143A1 | Mutated non-primate lentiviral env proteins and their use as drugs | |
EP2788372A1 | Mutated lentiviral env proteins and their use as drugs |